新研究调查Masimo PVi®在结直肠手术患者目标指导补液管理中的功用
土耳其伊兹密特 Masimo (NASDAQ: MASI)今天发布了近期发表的一项研究结果,土耳其科喀艾里大学的研究人员比较了择期结直肠手术患者传统补液管理(CFM)与采用Masimo PVi®(脉搏灌注变异指数,采用SET®脉搏氧饱和度仪传感器进行无创连续测量)的目标指导补液管理(GDFM)的功效。比较要点是手术期间晶体补液量和血乳酸及血清肌酐水平1。...
View Article大腸手術を受ける患者における目標指向型輸液管理の一環としてのMasimo PVi®の有用性を検討する新研究
トルコ・イズミット (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、最近公表されたトルコのコジャエリ大学の研究者らが最近公表した研究の知見について発表しました。本研究では、選択的大腸手術を受ける患者で、従来型輸液管理(CFM)と、Masimo...
View ArticleGynesonics Names George Quinoy Vice President, Global Sales
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for uterine fibroids, today announced that veteran medical device sales...
View ArticleAVITA Medical Announces Expansion of Management Team to Support Planned U.S....
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH) (OTCQX: AVMXY) today announced that it expanded its management team in the commercial, legal and medical affairs functions to...
View ArticleShionogi Announces FDA Approval of Mulpleta® (Lusutrombopag)
OSAKA, Japan & FLORHAM PARK, N.J. Shionogi & Co., Ltd. (hereafter “Shionogi”) announced today that, after completing a Priority Review, the U.S. Food and Drug Administration (FDA) has...
View ArticleAVITA Medical Announces Expanded Compassionate Use of RECELL® Device in...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that the U.S. Food and Drug Administration (FDA) has approved a significant increase in the number...
View ArticleSTAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic...
MONROVIA, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Dr. Maro Kariya of...
View ArticleAVITA Medical Announces Presentation of RECELL® Device Effectiveness and...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical...
View ArticleGynesonics Receives FDA Clearance to Market Sonata® System
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k)...
View ArticleAVITA Medical Announces Commencement of Manufacturing of RECELL® Device in...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced the successful completion of multiple production runs for the RECELL Device® within its newly...
View ArticleNew Study Compares Two Methods of Guiding Goal-Directed Fluid Therapy,...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today the findings of a study recently published in BMC Anesthesiology in which researchers at University Hospital Linköping, Sweden, compared...
View Article新研究比较两种指导目标导向补液治疗的方法:无创Masimo PVi®和侵入性食管多普勒超声
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布,《BMC麻醉学》(BMC Anesthesiology)最新发表了瑞典林彻平大学医院的一项研究成果,研究人员比较了两种目标导向补液治疗(GDFT)方法对开腹大手术患者的功效,一是采用侵入性食管多普勒超声,另一种是采用Masimo...
View ArticleSwiss Advanced Vision上市Harmonis – 首款用于白内障手术的可定制EDOF人工晶体
瑞士纳沙泰尔 (美国商业资讯) — Swiss Advanced Vision...
View ArticleSwiss Advanced Visionが初のカスタマイズ可能な白内障手術用EDOF IOLとなるHarmonisを発表
スイス・ヌーシャテル (ビジネスワイヤ) — Swiss Advanced...
View Article目標指向型輸液療法の指針となる非侵襲的Masimo PVi®および侵襲的経食道ドップラーの2手法を比較する新研究
スイス・ヌーシャテル (ビジネスワイヤ)– マシモ(NASDAQ: MASI)は本日、BMC Anesthesiology誌に最近掲載された研究の知見について発表しました。研究ではリンショーピン大学病院(スウェーデン)の研究者らが、腹部大手術を受ける患者で、侵襲的な経食道ドップラーによる目標指向型輸液療法(GDFT)の成績を、Masimo...
View ArticleAcelity签署协议,将Systagenix制造厂转让给Scapa Healthcare
圣安东尼奥 (美国商业资讯) — Acelity今天宣布一项协议,将其位于英格兰加格雷夫的先进伤口敷料制造厂出售给Scapa Healthcare。交易完成后,随同制造厂的转让,350多位员工也将并入Scapa,以支持与Acelity旗下公司KCI的一份制造协议。该制造协议将确保关键产品和配件的持续供货,这些产品和配件正在推进KCI在先进伤口敷料(AWD)领域的全球增长战略。...
View ArticleCardiovascular Systems, Inc. Announces First Commercial Launch of Peripheral...
ST. PAUL, Minn. Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral...
View ArticleAVITA Medical Announces Presentation of RECELL® System Effectiveness and...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that the results from two U.S. pivotal clinical trials...
View ArticleメダクタインターナショナルがFrancesco Siccardiを次期最高経営責任者に任命
スイス・カステルサンピエトロ (ビジネスワイヤ) — 革新的な人工関節置換術/脊椎手術関連製品の設計で世界をリードする家族所有の非上場企業メダクタインターナショナルは本日、著名な生物医学工学者でメダクタインターナショナルの現エグゼクティブバイスプレジデントのFrancesco...
View Article